Pharmaceutical Manufacturing – Topical Analgesic Patch

The contract entails the manufacture and supply of transdermal patches containing camphor, menthol, and methyl salicylate, specifically designed for topical analgesic use and fully compliant with all applicable FDA regulations, the Drug Supply Chain Security Act, and Department of Veterans Affairs packaging and labeling mandates. Production must adhere to strict quality control standards to ensure product safety, traceability, and consistency, with all labeling and packaging requirements aligned to VA-specific guidelines for distribution to veterans’ healthcare facilities. The work is structured as a subcontract under the NAICS code 325412, indicating pharmaceutical preparation manufacturing, and is being procured by the Department of Veterans Affairs through its National Cmop Office. The solicitation was posted on May 11, 2026, with a strict submission deadline of May 18, 2026, at 6:00 PM Eastern Time. While no set-aside preferences or small business designations are indicated, the contract requires full compliance with federal pharmaceutical manufacturing and distribution protocols, including DSCSA serialization and FDA-recognized good manufacturing practices. The place of performance details are unspecified, but the deliverables are intended for VA use, necessitating fulfillment of all federal healthcare supply chain requirements. Suppliers must be prepared to demonstrate capacity for bulk production, regulatory documentation, and secure, compliant packaging to meet VA distribution logistics.